(Q36740010)

16 August 2017

title

The current status of Helicobacter pylori vaccines: a review (English)

1 reference

Helicobacter pylori infectious disease

16 August 2017

1 reference

1 reference

Shahjahan Kabir

1

1 reference

16 August 2017

publication date

1 April 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

12

1 reference

16 August 2017

issue

2

1 reference

16 August 2017

page(s)

89-102

1 reference

A comprehensive review of the natural history of Helicobacter pylori infection in children.

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Mechanisms of acid resistance due to the urease system of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

The relation of Helicobacter pylori to gastric adenocarcinoma and lymphoma: pathophysiology, epidemiology, screening, clinical presentation, treatment, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

The translation of Helicobacter pylori basic research to patient care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Helicobacter infection and gastric neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Helicobacter pylori infection and the development of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Review article: clinic-based testing for Helicobacter pylori infection by enzyme immunoassay of faeces, urine and saliva

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Detection of Helicobacter pylori in faeces by culture, PCR and enzyme immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Antibiotic resistance in Helicobacter pylori: implications for therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

The design of vaccines against Helicobacter pylori and their development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Helicobacter pylori virulence factors: facts and fantasies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Supramolecular assembly and acid resistance of Helicobacter pylori urease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Characteristics of a clinical isolate of urease-negative Helicobacter pylori and its ability to induce gastric ulcers in Mongolian gerbils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

The Helicobacter pylori vacuolating cytotoxin: from cellular vacuolation to immunosuppressive activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Helicobacter pylori uses motility for initial colonization and to attain robust infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Cloning and genetic characterization of a Helicobacter pylori flagellin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Frequencies of the expression of main protein antigens from Helicobacter pylori isolates and production of specific serum antibodies in infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

The complete genome sequence of the gastric pathogen Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Comparative proteome analysis of Helicobacter pylori.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

A whole-genome microarray reveals genetic diversity among Helicobacter pylori strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Identification of immunodominant antigens from Helicobacter pylori and evaluation of their reactivities with sera from patients with different gastroduodenal pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Challenge model for Helicobacter pylori infection in human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

B-cell and T-cell immune responses to experimental Helicobacter pylori infection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Safety and efficacy of low dose Escherichia coli enterotoxin adjuvant for urease based oral immunisation against Helicobacter pylori in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Safety and efficacy of E coli enterotoxin adjuvant for urease-based rectal immunization against Helicobacter pylori.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

The quest for a vaccine against Helicobacter pylori: how to move from mouse to man?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Development of a mouse model of Helicobacter pylori infection that mimics human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Post-immunisation gastritis and Helicobacter infection in the mouse: a long term study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Analysis of aerotactic band formation by Desulfovibrio desulfuricans in a stopped-flow diffusion chamber

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Protective efficacy of anti-Helicobacter pylori immunity following systemic immunization of neonatal mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Immunisation against Helicobacter felis infection protects against the development of gastric MALT Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Protection against Helicobacter pylori infection in the Mongolian gerbil after prophylactic vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Therapeutic vaccination against Helicobacter pylori in the beagle dog experimental model: safety, immunogenicity, and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Generation of Helicobacter pylori ghosts by PhiX protein E-mediated inactivation and their evaluation as vaccine candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Suppressive effects of DNA vaccines encoding heat shock protein on Helicobacter pylori-induced gastritis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Immune responses in mice to intranasal and intracutaneous administration of a DNA vaccine encoding Helicobacter pylori-catalase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

A plasmid immunization construct encoding urease B of Helicobacter pylori induces an antigen-specific antibody response and upregulates the expression of beta-defensins and IL-10 in the stomachs of immunized mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Development and evaluation of a DNA vaccine based on Helicobacter pylori urease B: failure to prevent experimental infection in the mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Autodisplay: efficacious surface exposure of antigenic UreA fragments from Helicobacter pylori in Salmonella vaccine strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Construction of a recombinant attenuated Salmonella typhimurium DNA vaccine carrying Helicobacter pylori hpaA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Immunization of rhesus monkeys with a mucosal prime, parenteral boost strategy protects against infection with Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Enhanced mucosal and systemic immune responses to Helicobacter pylori antigens through mucosal priming followed by systemic boosting immunizations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Systemic immunization with urease protects mice against Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Mucosal immunization with helicobacter, CpG DNA, and cholera toxin is protective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Systemic Th1 immunization of mice against Helicobacter pylori infection with CpG oligodeoxynucleotides as adjuvants does not protect from infection but enhances gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

The nontoxic CTA1-DD adjuvant enhances protective immunity against Helicobacter pylori infection following mucosal immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Immune response to an 18-kilodalton outer membrane antigen identifies lipoprotein 20 as a Helicobacter pylori vaccine candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Early Helicobacter pylori colonisation: the association with growth faltering in The Gambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Decreased Helicobacter pylori-specific gastric secretory IgA antibodies in infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

In vitro comparison of the antigen-binding and stability properties of the various molecular forms of IgA antibodies assembled and produced in CHO cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Helicobacter pylori-specific antibodies impair the development of gastritis, facilitate bacterial colonization, and counteract resistance against infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

IgA antibodies impair resistance against Helicobacter pylori infection: studies on immune evasion in IL-10-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Augmentation of Helicobacter pylori urease activity by its specific IgG antibody: implications for bacterial colonization enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Murine CD4 T-cell response to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Vaccine-induced reduction of Helicobacter pylori colonization in mice is interleukin-12 dependent but gamma interferon and inducible nitric oxide synthase independent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Helicobacter pylori infection induces interleukin-18 production in gastric epithelial (AGS) cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Vaccine-induced immunity against Helicobacter pylori infection is impaired in IL-18-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Colonization of C57BL/6J and BALB/c wild-type and knockout mice with Helicobacter pylori: effect of vaccination and implications for innate and acquired immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Vaccine-induced protection against Helicobacter pylori in mice lacking both antibodies and interleukin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Immunity against Helicobacter pylori: significance of interleukin-4 receptor alpha chain status and gender of infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Clearance of Helicobacter pylori infection through immunization: the site of T cell activation contributes to vaccine efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Helicobacter pylori vaccine development: facing the challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Mast cells are critical mediators of vaccine-induced Helicobacter clearance in the mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Relationship between gastric ulcer and Helicobacter pylori VacA detected in gastric juice using bead-ELISA method

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

VacA-associated inhibition of T-cell function: reviewed and reconsidered

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

A secreted low-molecular-weight protein from Helicobacter pylori induces cell-cycle arrest of T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Helicobacter pylori arginase inhibits T cell proliferation and reduces the expression of the TCR zeta-chain (CD3zeta).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Natural antibiotic function of a human gastric mucin against Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00478.X

Unique cholesteryl glucosides in Helicobacter pylori: composition and structural analysis

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1128/JB.177.18.5327-5333.1995

Identifiers

DOI

10.1111/J.1523-5378.2007.00478.X

1 reference

16 August 2017

1 reference